Stocksigma LogoStocksigma Logo

Emmessar Biotech Q2 FY27 Financial Results

Emmessar Biotech & Nutrition published its unaudited financial results for the quarter ended 30th Sep'26

Emmessar Biotech Q2 FY27 Financial Results

Emmessar Biotech & Nutrition Ltd · Others (Uncategorized) · 02 Nov 2026, 8:36 pm

Emmessar Biotech Q2 FY27 Financial Results Emmessar Biotech & Nutrition published its unaudited financial results for the quarter ended 30th Sep'26. Total revenue reached ₹62.50 lakh, compared to ₹59.85 lakh in Q1 FY27 and ₹63.04 lakh in Q2 FY26. Total expenses stood at ₹45.24 lakh versus ₹43.55 lakh in the preceding quarter. Net profit after tax came in at ₹14.03 lakh, up slightly from ₹13.15 lakh in Q1 FY27 and ₹11.46 lakh in Q2 FY26. Basic and diluted EPS for the quarter was reported at ₹0.28.

Original exchange filing (PDF)

More announcements from Emmessar Biotech & Nutrition Ltd

All Emmessar Biotech & Nutrition Ltd announcements